These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 16127375

  • 1. Chemotherapeutics targeting immune activation by staphylococcal superantigens.
    Krakauer T.
    Med Sci Monit; 2005 Sep; 11(9):RA290-5. PubMed ID: 16127375
    [Abstract] [Full Text] [Related]

  • 2. Therapeutic down-modulators of staphylococcal superantigen-induced inflammation and toxic shock.
    Krakauer T.
    Toxins (Basel); 2010 Aug; 2(8):1963-83. PubMed ID: 22069668
    [Abstract] [Full Text] [Related]

  • 3. Staphylococcal Superantigens: Pyrogenic Toxins Induce Toxic Shock.
    Krakauer T.
    Toxins (Basel); 2019 Mar 23; 11(3):. PubMed ID: 30909619
    [Abstract] [Full Text] [Related]

  • 4. PI3K/Akt/mTOR, a pathway less recognized for staphylococcal superantigen-induced toxicity.
    Krakauer T.
    Toxins (Basel); 2012 Nov 15; 4(11):1343-66. PubMed ID: 23202320
    [Abstract] [Full Text] [Related]

  • 5. Toxic shock syndrome toxin-1-induced death is prevented by CTLA4Ig.
    Saha B, Jaklic B, Harlan DM, Gray GS, June CH, Abe R.
    J Immunol; 1996 Nov 01; 157(9):3869-75. PubMed ID: 8892617
    [Abstract] [Full Text] [Related]

  • 6. Superantigen natural affinity maturation revealed by the crystal structure of staphylococcal enterotoxin G and its binding to T-cell receptor Vbeta8.2.
    Fernández MM, Bhattacharya S, De Marzi MC, Brown PH, Kerzic M, Schuck P, Mariuzza RA, Malchiodi EL.
    Proteins; 2007 Jul 01; 68(1):389-402. PubMed ID: 17427250
    [Abstract] [Full Text] [Related]

  • 7. Immune response to staphylococcal superantigens.
    Krakauer T.
    Immunol Res; 1999 Jul 01; 20(2):163-73. PubMed ID: 10580640
    [Abstract] [Full Text] [Related]

  • 8. Structural dichotomy of staphylococcal enterotoxin C superantigens leading to MHC class II-independent activation of T lymphocytes.
    Lamphear JG, Bohach GA, Rich RR.
    J Immunol; 1998 Mar 01; 160(5):2107-14. PubMed ID: 9498747
    [Abstract] [Full Text] [Related]

  • 9. Update on staphylococcal superantigen-induced signaling pathways and therapeutic interventions.
    Krakauer T.
    Toxins (Basel); 2013 Sep 24; 5(9):1629-54. PubMed ID: 24064719
    [Abstract] [Full Text] [Related]

  • 10. Acute systemic immune activation following vaginal exposure to staphylococcal enterotoxin B--implications for menstrual shock.
    Rajagopalan G, Smart MK, Murali N, Patel R, David CS.
    J Reprod Immunol; 2007 Feb 24; 73(1):51-9. PubMed ID: 17070600
    [Abstract] [Full Text] [Related]

  • 11. Staphylococcal Superantigens Spark Host-Mediated Danger Signals.
    Krakauer T, Pradhan K, Stiles BG.
    Front Immunol; 2016 Feb 24; 7():23. PubMed ID: 26870039
    [Abstract] [Full Text] [Related]

  • 12. Superantigen antagonist protects against lethal shock and defines a new domain for T-cell activation.
    Arad G, Levy R, Hillman D, Kaempfer R.
    Nat Med; 2000 Apr 24; 6(4):414-21. PubMed ID: 10742148
    [Abstract] [Full Text] [Related]

  • 13. Defense against biologic warfare with superantigen toxins.
    Kaempfer R, Arad G, Levy R, Hillman D.
    Isr Med Assoc J; 2002 Jul 24; 4(7):520-3. PubMed ID: 12120463
    [Abstract] [Full Text] [Related]

  • 14. Vbeta-restricted T cell adherence to endothelial cells: a mechanism for superantigen-dependent vascular injury.
    Brogan PA, Shah V, Klein N, Dillon MJ.
    Arthritis Rheum; 2004 Feb 24; 50(2):589-97. PubMed ID: 14872503
    [Abstract] [Full Text] [Related]

  • 15. Staphylococcal superantigens as inducers of signal transduction in MHC class II-positive cells.
    Mourad W, al-Daccak R, Chatila T, Geha RS.
    Semin Immunol; 1993 Feb 24; 5(1):47-55. PubMed ID: 8467095
    [Abstract] [Full Text] [Related]

  • 16. Cyclooxygenase 2 pathway and its therapeutic inhibition in superantigen-induced toxic shock.
    Rajagopalan G, Asmann YW, Lytle AK, Tilahun AY, Theuer JE, Smart MK, Patel R, David CS.
    Shock; 2008 Dec 24; 30(6):721-8. PubMed ID: 18496243
    [Abstract] [Full Text] [Related]

  • 17. Analysis of superantigenic toxin Vbeta T-cell signatures produced during cases of staphylococcal toxic shock syndrome and septic shock.
    Ferry T, Thomas D, Perpoint T, Lina G, Monneret G, Mohammedi I, Chidiac C, Peyramond D, Vandenesch F, Etienne J.
    Clin Microbiol Infect; 2008 Jun 24; 14(6):546-54. PubMed ID: 18373692
    [Abstract] [Full Text] [Related]

  • 18. Superantigen antagonist blocks Th1 cytokine gene induction and lethal shock.
    Arad G, Hillman D, Levy R, Kaempfer R.
    J Leukoc Biol; 2001 Jun 24; 69(6):921-7. PubMed ID: 11404377
    [Abstract] [Full Text] [Related]

  • 19. A broad-spectrum inhibitory peptide against staphylococcal enterotoxin superantigen SEA, SEB and SEC.
    Wang S, Li Y, Xiong H, Cao J.
    Immunol Lett; 2008 Dec 22; 121(2):167-72. PubMed ID: 19028523
    [Abstract] [Full Text] [Related]

  • 20. Human antibodies to bacterial superantigens and their ability to inhibit T-cell activation and lethality.
    LeClaire RD, Bavari S.
    Antimicrob Agents Chemother; 2001 Feb 22; 45(2):460-3. PubMed ID: 11158741
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.